Skip to content

ABLD · Euronext Paris · ISIN FR001400AHX6

ABL Texcell Diagnostics, Advanced Biological Laboratories
UltraGene®CE-IVD

UltraGene Assay SARS-CoV-2 VOC Screening & Determination V1.X

Variants of concern

SARS-CoV-2

Overview

The U ltraGene Assay SARS CoV 2 VOC Screening and Determination V1 (CE IVD) is a rtRT PCR Assay (nucleic acid technique ( intended for the qualitative detection of SARS CoV 2 mutations L452R, K417N or K417T, E484A or E484K or E484Q, and the deletion 69 70 on the Spike gene. The test is targeting the S and N regions of SARS CoV 2 patients’ extracted RNA and already diagnosed PCR positive to SARS CoV 2

Specifications

Specimens

  • Upper respiratory specimens (nasal, mid-turbinate, nasopharyngeal, oropharyngeal swab specimens and nasopharyngeal wash/aspirate or nasal aspirate and bronchoalveolar lavage (BAL) fluid specimens (already tested SARS-CoV-2 positive).

Formats

  • 50 or 1000 tests per kit
  • Multiplex format in 2 wells per sample

Kit contents

  • Master Mix 2X, RT Mix, Enzyme Mix and Magnesium Sulfate
  • Specific Primers & Probes for each mutation (del 69-70, K417N, K417T, L452R, E484K, E484A) from S gene
  • Positive control
  • Negative control
  • Internal control (N-gene)
  • PCR grade nuclease-free water

Extraction

  • Magnetic beads

Compatible instruments

  • Any qPCR instrument compatible with the FAM, HEX, ROX and Cy5 channels.
  • Validated for use with C1000 Dx Thermal Cycler (Bio-Rad, Catalog # 1841000-IVD with CFX96-Dx ORM software version 3.1) (C1000 CFX96)

Workflow

  • <2h